{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"dihydropteridine-reductase-deficiency","columns":[{"gene":"","key":"population-f3a171e611f4f88cc16f","label":"Hyperphenylalaninemia, bh4-deficient, C","mondoId":"MONDO:0009862","onsetQualifier":null,"originColumnKey":"MONDO:0009862/OMIM:261630","originalViews":[{"key":"MONDO:0009862/OMIM:261630","label":"Hyperphenylalaninemia, bh4-deficient, C","scopeLabel":"OMIM:261630","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["01a74f64855926041f5413a8efd54caf51125e03e0a563a478fc99d492341329","0dfadd0cfafe09b0c2623703ab7d62d3612bab198072df390cfde85e20409eaa","1163751e84dca7b0b35d317135461a2385ca4416d8aa7a3cd48f1bbe66c24e23","31edc195afbb000491dbb765c6dae766c8edb66b0cc3672f25e4cc13b12d9662","40a78911fa9b432aa125b153ef036f7eb31e5fb1f9f1542cee76604edc4bc2c0","45801990ebc48282cffef48bc5c3d519ff1aa2d3e35d9c8a514a90e1e69edbf3","5414f1d834a7501b0ae6d29835ad88805e779e60d9cfcb9f50567621f8d29316","5f73d684089522f6cf627c0a5f3db13082ac42155ca6c80c5fbfc61ef5444451","6309ee66d5e9017962dff7c93c2508880f42c35771bc72418485dbd69cddcd79","7220e74f01049a77a857ab7fde9d0ac7e780effa3f7d0d4cf16f91c7af989e57","8d8905db097055d83b421d6873d813c9d0840bd451b005d4bbb21b8b3c6856eb","a0570bdb9c8453e397ae73eea386028205ed64de498e0e90e3dc63c70796ca70","adba2944a18c2dafc432f0f4ded91a3110eb8bb5762267cc8f47df012f1b6f7e","be73763963f28306aedea984d9edaa27f6fcfb9285dad12dceca57000481e5b3","c155f48da1686d5644e89330aff705f1ab91d4e6b9378901d06f198a1163e7ee","dad8116c39ccf6124d8b947cd81e2e69a8aea8f99022996ef9ec39865dab9de5","de8bae77328d579fa6177f1829a87a177f6e2f00f768fea9574c6ee4df332c3e","fbb7da149ddf7fac9858420a0c5b9e0fa4014c3cbf4dd6bb78cdf05c17b9747e"],"recordQualifiers":{},"scopeLabel":"OMIM:261630","sourceIds":["OMIM:261630"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."},{"gene":"","key":"population-6fb900e487c9cce90626","label":"Dihydropteridine reductase deficiency","mondoId":"MONDO:0009862","onsetQualifier":null,"originColumnKey":"MONDO:0009862/ORPHA:226","originalViews":[{"key":"MONDO:0009862/ORPHA:226","label":"Dihydropteridine reductase deficiency","scopeLabel":"ORPHA:226","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["711742cd412cef42f915df0a256f883bacd59847a947c421f18ba32f32e32885","84ebbee9fdbad7d7a2837d15ce34fdfb8ba2266ea84efc205133d40ffa19bb26","c0221a8b57fe074fd18424537f4c2928dfab1f2f107af66a9bc9688584ccfca1","fa14af87d684ea1c3156894e5e0616fc5475ba45f9aff99e07c3358fe719e31a"],"recordQualifiers":{},"scopeLabel":"ORPHA:226","sourceIds":["ORPHA:226"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-f3a171e611f4f88cc16f","population-6fb900e487c9cce90626"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0002514","HP:0001266","HP:6000966","HP:0002015","HP:0001332","HP:0003781","HP:0001263"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":2,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":22,"sourceGroups":{"omim":17,"orphanet":4,"published":1}},"features":[{"hpoId":"HP:0002514","label":"Cerebral calcification","primary":true},{"hpoId":"HP:0001266","label":"Choreoathetosis","primary":true},{"hpoId":"HP:6000966","label":"Diminished tissue dihydropteridine reductase activity","primary":true},{"hpoId":"HP:0002015","label":"Dysphagia","primary":true},{"hpoId":"HP:0001332","label":"Dystonia","primary":true},{"hpoId":"HP:0003781","label":"Excessive salivation","primary":true},{"hpoId":"HP:0001263","label":"Global developmental delay","primary":true},{"hpoId":"HP:0004923","label":"Hyperphenylalaninemia","primary":false},{"hpoId":"HP:0001276","label":"Hypertonia","primary":false},{"hpoId":"HP:0001252","label":"Hypotonia","primary":false},{"hpoId":"HP:0001249","label":"Intellectual disability","primary":false},{"hpoId":"HP:0000737","label":"Irritability","primary":false},{"hpoId":"HP:0000252","label":"Microcephaly","primary":false},{"hpoId":"HP:0001336","label":"Myoclonus","primary":false},{"hpoId":"HP:0002344","label":"Progressive neurologic deterioration","primary":false},{"hpoId":"HP:0001954","label":"Recurrent fever","primary":false},{"hpoId":"HP:0001250","label":"Seizure","primary":false},{"hpoId":"HP:0001337","label":"Tremor","primary":false}],"ledeHtml":"Dihydropteridine reductase (DHPR) deficiency is characterized by hyperphenylalaninemia, abnormal muscle tone (trunk hypotonia and distal hypertonia), and autonomic dysfunction (hypersalivation, impaired temperature regulation, sweating). Without treatment, movement disorders, developmental delays, and intellectual disability develop. More than half of individuals have seizures. Neurobehavioral and psychiatric manifestations and microcephaly occur in some individuals. Early treatment prevents the most severe clinical manifestations but delays in neurocognitive development can still develop.","mondoId":"MONDO:0009862","node":{"canonicalSlug":"dihydropteridine-reductase-deficiency","comparisons":[{"documentSha256":"1b2ba03faf0835d34ab5fe783adec9475ff848f02dabd1617924e0a51f4823af","key":"legacy-hyperphenylalaninemia-due-to-tetrahydrobiopterin-deficiency","kind":"legacy","label":"hyperphenylalaninemia due to tetrahydrobiopterin deficiency","memberIds":["MONDO:0009862","MONDO:0009863","MONDO:0009908","MONDO:0016543","MONDO:0100186"],"mondoId":"MONDO:0016543","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/hyperphenylalaninemia-due-to-tetrahydrobiopterin-deficiency.1b2ba03faf0835d34ab5fe783adec9475ff848f02dabd1617924e0a51f4823af.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"summary","matchMethod":"automatic-preferred-title","name":"Dihydropteridine Reductase Deficiency","paragraphs":["Dihydropteridine reductase (DHPR) deficiency is characterized by hyperphenylalaninemia, abnormal muscle tone (trunk hypotonia and distal hypertonia), and autonomic dysfunction (hypersalivation, impaired temperature regulation, sweating). Without treatment, movement disorders, developmental delays, and intellectual disability develop. More than half of individuals have seizures. Neurobehavioral and psychiatric manifestations and microcephaly occur in some individuals. Early treatment prevents the most severe clinical manifestations but delays in neurocognitive development can still develop."],"reviewed":"2026-06-02","scope":"exact","source":"GeneReviews","sourceExcerpt":"Summary / Clinical characteristics","sourceRelease":"2026-10-18 12:12:05.458042+00","upstream":"GeneReviews clinical characteristics","url":"https://www.ncbi.nlm.nih.gov/books/NBK622830/"},"ownColumnKeys":["population-f3a171e611f4f88cc16f","population-6fb900e487c9cce90626"],"publication":"published","relationships":[{"kind":"parent","label":"hyperphenylalaninemia due to tetrahydrobiopterin deficiency","mondoId":"MONDO:0016543","slug":"hyperphenylalaninemia-due-to-tetrahydrobiopterin-deficiency"},{"kind":"parent","label":"tetrahydrobiopterin metabolic process disease","mondoId":"MONDO:0045014","slug":"tetrahydrobiopterin-metabolic-process-disease"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[{"reason":"multiple-identity-targets","source":"MedlinePlus","url":"https://medlineplus.gov/genetics/condition/tetrahydrobiopterin-deficiency"}],"translation":"published","articles":[{"articleId":"rarediseases.info.nih.gov/diseases/4319","pageMondoId":"MONDO:0009862","source":"GARD","name":"Dihydropteridine reductase deficiency","url":"https://rarediseases.info.nih.gov/diseases/4319","relationToPage":"same-condition","coveredMondoIds":["MONDO:0009862"],"status":"validated-exact-source","presentation":"additional-reference","evidence":["existing-offline-scope-validator","automatic-identity-and-attribution"],"reviewed":null,"sourceRelease":"2026-10-25T03:39:12Z","upstream":"GARD:0004319","rawAttribution":"MONDO:0009862","independentCorroborationEstablished":false}]},"records":[{"frequencyKind":"reported","key":"01a74f64855926041f5413a8efd54caf51125e03e0a563a478fc99d492341329","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:261630","disease_name":"Hyperphenylalaninemia, bh4-deficient, C","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001336","is_excluded":false,"label":"Myoclonus","onset_id":null,"reference":"OMIM:261630","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"0dfadd0cfafe09b0c2623703ab7d62d3612bab198072df390cfde85e20409eaa","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:261630","disease_name":"Hyperphenylalaninemia, bh4-deficient, C","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001252","is_excluded":false,"label":"Hypotonia","onset_id":null,"reference":"OMIM:261630","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"1163751e84dca7b0b35d317135461a2385ca4416d8aa7a3cd48f1bbe66c24e23","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:261630","disease_name":"Hyperphenylalaninemia, bh4-deficient, C","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001276","is_excluded":false,"label":"Hypertonia","onset_id":null,"reference":"OMIM:261630","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"31edc195afbb000491dbb765c6dae766c8edb66b0cc3672f25e4cc13b12d9662","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:261630","disease_name":"Hyperphenylalaninemia, bh4-deficient, C","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001954","is_excluded":false,"label":"Recurrent fever","onset_id":null,"reference":"OMIM:261630","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"40a78911fa9b432aa125b153ef036f7eb31e5fb1f9f1542cee76604edc4bc2c0","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:261630","disease_name":"Hyperphenylalaninemia, bh4-deficient, C","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001332","is_excluded":false,"label":"Dystonia","onset_id":null,"reference":"OMIM:261630","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"45801990ebc48282cffef48bc5c3d519ff1aa2d3e35d9c8a514a90e1e69edbf3","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:261630","disease_name":"Hyperphenylalaninemia, bh4-deficient, C","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001250","is_excluded":false,"label":"Seizure","onset_id":null,"reference":"OMIM:261630","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"5414f1d834a7501b0ae6d29835ad88805e779e60d9cfcb9f50567621f8d29316","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:261630","disease_name":"Hyperphenylalaninemia, bh4-deficient, C","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0004923","is_excluded":false,"label":"Hyperphenylalaninemia","onset_id":null,"reference":"OMIM:261630","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"5f73d684089522f6cf627c0a5f3db13082ac42155ca6c80c5fbfc61ef5444451","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:261630","disease_name":"Hyperphenylalaninemia, bh4-deficient, C","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001337","is_excluded":false,"label":"Tremor","onset_id":null,"reference":"OMIM:261630","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"6309ee66d5e9017962dff7c93c2508880f42c35771bc72418485dbd69cddcd79","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:261630","disease_name":"Hyperphenylalaninemia, bh4-deficient, C","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001249","is_excluded":false,"label":"Intellectual disability","onset_id":null,"reference":"OMIM:261630","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"711742cd412cef42f915df0a256f883bacd59847a947c421f18ba32f32e32885","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:226","disease_name":"Dihydropteridine reductase deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001249","is_excluded":false,"label":"Intellectual disability","onset_id":null,"reference":"ORPHA:226","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"7220e74f01049a77a857ab7fde9d0ac7e780effa3f7d0d4cf16f91c7af989e57","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:261630","disease_name":"Hyperphenylalaninemia, bh4-deficient, C","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0002344","is_excluded":false,"label":"Progressive neurologic deterioration","onset_id":null,"reference":"OMIM:261630","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"84ebbee9fdbad7d7a2837d15ce34fdfb8ba2266ea84efc205133d40ffa19bb26","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:226","disease_name":"Dihydropteridine reductase deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0002015","is_excluded":false,"label":"Dysphagia","onset_id":null,"reference":"ORPHA:226","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"8d8905db097055d83b421d6873d813c9d0840bd451b005d4bbb21b8b3c6856eb","raw":{"aspect":"P","body_system":"head_and_neck","disease_id":"OMIM:261630","disease_name":"Hyperphenylalaninemia, bh4-deficient, C","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0003781","is_excluded":false,"label":"Excessive salivation","onset_id":null,"reference":"OMIM:261630","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"a0570bdb9c8453e397ae73eea386028205ed64de498e0e90e3dc63c70796ca70","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:261630","disease_name":"Hyperphenylalaninemia, bh4-deficient, C","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000252","is_excluded":false,"label":"Microcephaly","onset_id":null,"reference":"OMIM:261630","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"adba2944a18c2dafc432f0f4ded91a3110eb8bb5762267cc8f47df012f1b6f7e","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:261630","disease_name":"Hyperphenylalaninemia, bh4-deficient, C","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000737","is_excluded":false,"label":"Irritability","onset_id":null,"reference":"OMIM:261630","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"be73763963f28306aedea984d9edaa27f6fcfb9285dad12dceca57000481e5b3","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:261630","disease_name":"Hyperphenylalaninemia, bh4-deficient, C","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0002514","is_excluded":false,"label":"Cerebral calcification","onset_id":null,"reference":"OMIM:261630","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"c0221a8b57fe074fd18424537f4c2928dfab1f2f107af66a9bc9688584ccfca1","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:226","disease_name":"Dihydropteridine reductase deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001263","is_excluded":false,"label":"Global developmental delay","onset_id":null,"reference":"ORPHA:226","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"c155f48da1686d5644e89330aff705f1ab91d4e6b9378901d06f198a1163e7ee","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:261630","disease_name":"Hyperphenylalaninemia, bh4-deficient, C","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0002015","is_excluded":false,"label":"Dysphagia","onset_id":null,"reference":"OMIM:261630","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"dad8116c39ccf6124d8b947cd81e2e69a8aea8f99022996ef9ec39865dab9de5","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:261630","disease_name":"Hyperphenylalaninemia, bh4-deficient, C","evidence":"IEA","frequency_raw":"20/20","hpo_id":"HP:0001263","is_excluded":false,"label":"Global developmental delay","onset_id":null,"reference":"OMIM:261630","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"de8bae77328d579fa6177f1829a87a177f6e2f00f768fea9574c6ee4df332c3e","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:261630","disease_name":"Hyperphenylalaninemia, bh4-deficient, C","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001266","is_excluded":false,"label":"Choreoathetosis","onset_id":null,"reference":"OMIM:261630","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"fa14af87d684ea1c3156894e5e0616fc5475ba45f9aff99e07c3358fe719e31a","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:226","disease_name":"Dihydropteridine reductase deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000252","is_excluded":false,"label":"Microcephaly","onset_id":null,"reference":"ORPHA:226","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"fbb7da149ddf7fac9858420a0c5b9e0fa4014c3cbf4dd6bb78cdf05c17b9747e","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:261630","disease_name":"Hyperphenylalaninemia, bh4-deficient, C","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:6000966","is_excluded":false,"label":"Diminished tissue dihydropteridine reductase activity","onset_id":null,"reference":"PMID:7110817","source_release":"2026-06-23"},"sourceGroups":["published"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://www.ncbi.nlm.nih.gov/books/NBK622830/\" rel=\"noreferrer\">GeneReviews</a></p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/4319\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0009862\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-preferred-title</dd><dt>Upstream attribution</dt><dd>GeneReviews clinical characteristics</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Dihydropteridine reductase (DHPR) deficiency is characterized by hyperphenylalaninemia, abnormal muscle tone (trunk hypotonia and distal hypertonia), and autonomic dysfunction (hypersalivation, impaired temperature regulation, sweating). Without treatment, movement disorders, developmental delays, and intellectual disability develop. More than half of individuals have seizures. Neurobehavioral and psychiatric manifestations and microcephaly occur in some individuals. Early treatment prevents the most severe clinical manifestations but delays in neurocognitive development can still develop.</p><p class=\"section-source\">Source: <a href=\"https://www.ncbi.nlm.nih.gov/books/NBK622830/\" rel=\"noreferrer\">GeneReviews</a></p>","key":"overview","title":"Overview"}],"sharedSources":[],"slug":"dihydropteridine-reductase-deficiency","sourceDocuments":[{"name":"GeneReviews: Dihydropteridine Reductase Deficiency","reviewed":"2026-06-02","source_release":"2026-10-18 12:12:05.458042+00","url":"https://www.ncbi.nlm.nih.gov/books/NBK622830/"},{"name":"GARD: Dihydropteridine reductase deficiency","reviewed":null,"source_release":"2026-10-25T03:39:12Z","url":"https://rarediseases.info.nih.gov/diseases/4319"},{"name":"MONDO: dihydropteridine reductase deficiency","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0009862"}],"sourceNote":"","synonyms":["6,7-dihydropteridine reductase activity disease","dihydropteridine reductase deficiency","disorder of 6,7-dihydropteridine reductase activity","HPABH4C","hyperphenylalaninemia due to dihydropteridine reductase deficiency","hyperphenylalaninemia, BH-4-deficient, C","hyperphenylalaninemia, BH4-deficient C","hyperphenylalaninemia, BH4-deficient, C","hyperphenylalaninemia, Bh4-deficient, type C","phenylketonuria type 2","PKU type 2"],"takeawayHtml":"","title":"dihydropteridine reductase deficiency"},"schemaVersion":1}
